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Abstract
The aim of this study was to evaluate changes in the expression of cannabinoid type 1 (CB1) and 2 (CB2) receptor proteins in
several brain regions in rats undergoing cocaine self-administration and extinction training. We used a triad-yoked procedure to
distinguish between the motivational and pharmacological effects of cocaine. Using immunohistochemistry, we observed a
significant decrease in CB1 receptor expression in the prefrontal cortex, dorsal striatum, and the basolateral and basomedial
amygdala following cocaine (0.5 mg/kg/infusion) self-administration. Increased CB1 receptor expression in the ventral tegmen-
tal area in rats with previous cocaine exposure was also found. Following cocaine abstinence after 10 days of extinction training,
we detected increases in the expression of CB1 receptors in the substantia nigra in both cocaine groups and in the subregions of
the amygdala for only the yoked cocaine controls, while any method of cocaine exposure resulted in a decrease in CB2 receptor
expression in the prefrontal cortex (p < 0.01), nucleus accumbens (p < 0.01), and medial globus pallidus (p < 0.01). Our findings
further support the idea that the eCB system and CB1 receptors are involved in cocaine-reinforced behaviors. Moreover, we
detected a cocaine-evoked adaptation in CB2 receptors in the amygdala, prefrontal cortex, and globus pallidus.
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Introduction
Cocaine is one of the most psychoactive drugs that leads to
substance use disorder. The principal mechanism of action of
cocaine is via monoamine (dopamine, noradrenaline, and se-
rotonin) reuptake inhibition, which in turn enhances the syn-
aptic concentration of these neurotransmitters (Jastrzębska et
al. 2015; Nestler 2004; Wydra et al. 2013). Recently, it was
discovered that cocaine may exert direct and/or indirect allo-
steric enhancing effects at dopamine (DA) D2 receptors
(Ferraro et al. 2010), while cocaine use disorder is associated
with a reduced density of striatal DA D2 receptor expression
in the striatum (Blum et al. 2012). Interestingly, in rat striatal
slices, cocaine—via D2-like receptor activation—and the D2-
like receptor agonist quinpirole enhance the synthesis of the
endocannabinoid anandamide and inhibit its degradation
(Centonze et al. 2004), while in vivo, quinpirole stimulates
the striatal release of anandamide in rats (Giuffrida et al.
1999). Functional crosstalk between D2 receptors and the
endocannabinoid system also exists at the intracellular path-
way level (Alonso et al. 1999; André and Gonthier 2010;
Chiang et al. 2013; Fuxe at al. 2010).
Apart from anandamide, the endocannabinoid system in-
cludes another endogenous ligand (2-arachidonoylglycerol),
enzymes responsible for the synthesis and degradation of
endocannabinoids and G protein-coupled cannabinoid recep-
tors, namely CB1 and CB2. The CB1 receptors are localized
mainly in brain neurons, and their distribution depends on the
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structure in which they are found: the highest densities of CB1
receptors are found in the basal ganglia, hippocampus, and
cerebellum (Herkenham et al. 1990, 1991; Thomas et al.
1992). CB1 receptors are also present in glutamatergic and
GABAergic nerve endings (Kano et al. 2009; Wilson and
Nicoll 2002).
CB2 receptors were initially recognized only in the im-
mune system, however, although their presence has now been
demonstrated in the brain as well (Engeli 2012; Gong et al.
2006; Onaivi et al. 2006; Van Sickle et al. 2005; Viscomi et al.
2009). In the brain, CB2 receptor transcripts and/or proteins
have been detected in the retina (Lu et al. 2000), cortex, cere-
bral cortex (Ashton et al. 2006), hippocampus, amygdala, stri-
atum, and brainstem (Van Sickle et al. 2005). In the above
brain areas, the cellular localization of CB2 receptors is linked
to the presence of microglia (Malfitano et al. 2014); however,
but a recent study has also shown the expression of these
receptors in DA neurons in the ventral tegmental area
(Zhang et al. 2014; Zhang et al. 2016).
There are several reports supporting the control of the
endocannabinoid system over cocaine use disorder, although
the data are conflicting. At the behavioral level, the lack of
CB1 receptors in mice (Soria et al. 2005) or pretreatment with
a CB1 receptor agonist in rats (Fattore et al. 1999) reduces
cocaine self-administration. Other pharmacological analyses
using CB1 receptor antagonists do not reveal their effects on
cocaine-reinforcing properties in rodents (Adamczyk et al.
2012b; Cossu et al. 2001; Lesscher et al. 2005), while the
brain’s CB2 receptors were found to modulate the rewarding
effect of cocaine (Xi et al. 2011; Zhang et al. 2014). The other
discrepant data show that CB1 and CB2 receptor blockade
attenuates the reinstatement of the drug and cue-associated
cocaine-seeking behavior (Filip et al. 2006; Xi et al. 2006;
Adamczyk et al. 2012b), while both stimulation and blockade
of CB1 receptors play an important role in drug- as well as in
cue-induced reinstatement of cocaine-seeking behavior
(Fattore et al. 2007) in rats. A recent separate study by
McReynolds et al. (2016) demonstrates that CB1 receptor
antagonism blocks stress-potentiated reinstatement of cocaine
seeking in rats (McReynolds et al. 2016).
Using autoradiographic procedures, it has been shown that
either cocaine self-administration (Adamczyk et al. 2012a) or
passive drug injections (Gonzalez et al. 2002; Centonze et al.
2004) evoke neuroadaptive changes in CB1 receptor density,
which depend on the brain structure examined and last until
drug abstinence occurs. On the other hand, García-Cabrerizo
and García-Fuster (2016) with using Western blot analyses
showed opposite and transient regulation of CB1 (increases)
and CB2 (decreases) receptors in the prefrontal cortex of rats
treated with cocaine during early adolescence (García-
Cabrerizo and García-Fuster 2016). In cocaine addicts as well
as in chronic cocaine-treated rodents, a reduction in CB1 re-
ceptor protein (but not in CB2 receptor protein) in the
prefrontal cortex was demonstrated (Álvaro-Bartolomé and
García-Sevilla 2013). Our findings related to the eCB brain
levels during cocaine self-administration, yoked cocaine de-
livery, and cocaine withdrawal demonstrate significant chang-
es in brain tissue endocannabinoid (eCB) levels and further
support the significance of the eCB system in the reinforce-
ment and extinction of positively reinforced behaviors
(Bystrowska et al. 2014).
In view of these data, we used a triad-yoked procedure to
distinguish between the motivational and pharmacological ef-
fects of cocaine, plus to evaluate the changes in the expression
of CB1 and CB2 receptors in different rat brain structures in
relation to the administration of cocaine in cellular
membranes.
Materials and Methods
Animals
Male Wistar rats (280–300 g, N = 46) were delivered by a
licensed breeder (Charles River, Germany) and were housed
individually in standard plastic rodent cages in an animal col-
ony room maintained at 20 ± 1 °C and at 40–50% humidity
under a 12-h light-dark cycle (lights on at 06:00). The animals
had free access to standard animal food and water during the
7-day habituation period. All of the experiments were con-
ducted during the light phase of the light-dark cycle (between
08:00 and 15:00) and were carried out in accordance with the
National Institutes of Health Guide for the Care and Use of
Laboratory Animals and with the approval of the Bioethics
Commission in compliance with Polish Law (21 August
1997). The animals were experimentally naive.
Drugs
Cocaine hydrochloride (Sigma-Aldrich, St. Louis, USA) was
dissolved in sterile 0.9% NaCl and given iv (0.1 ml/infusion).
Behavioral Procedures
Cocaine Self-Administration and Extinction Training
Rats were trained to press the lever of standard operant con-
ditioning chambers (Med-Associates, USA) under an increas-
ing schedule of water reinforcement at a fixed ratio of 1 to 5.
Two days following the Blever-press^ training under FR5 con-
ditions and with free access to water, the rats were chronically
implanted with a silastic catheter in the external right jugular
vein, as described previously (Frankowska et al. 2010). The
catheters were flushed every day with 0.1 ml of a saline solu-
tion containing heparin (70 U/ml, Biochemie GmbH, Austria)
and 0.1 ml of a cefazolin solution (10 mg/ml; Biochemie
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GmbH, Austria). There were no problems with catheter
patency.
After a 7- to 8-day recovery period, all of the animals were
water-deprived for 18 h and trained to press the lever at an FR
5 schedule of water reinforcement over a 2-h session for
14 days. The subjects were then given access to cocaine dur-
ing 2-h daily sessions performed 6 days/week (maintenance),
and during that time, they were given water ad libitum. The
house lights were illuminated throughout each session. Each
completion of five presses on the Bactive^ lever complex (a
FR 5 schedule) resulted in a 5-s infusion of cocaine (0.5mg/kg
per 0.1 ml) and a 5-s presentation of a stimulus complex (the
activation of a white stimulus light directly above the active
lever and a tone generator set at 2000 Hz and 15 dB above the
ambient noise levels). Following each injection, there was a
20-s time-out period during which responses were recorded
but no programmed consequences occurred. Responses in-
volving the Binactive^ lever resulted in no delivery of cocaine.
The acquisition of the conditioned operant response until the
subjects met the following criteria: active lever presses over an
average of three consecutive days and with a standard devia-
tion within those 3 days of < 10% of the average number of
lever presses. This criterion was selected based on our prior
experiments (Filip et al. 2006). After the 14th (2-h) self-
administration session, the animals were decapitated (group
1; N = 6).
Separate groups of animals trained to self-administer co-
caine (0.5 mg/kg/inf) for 14 days were exposed to the extinc-
tion training. During the extinction sessions, the subjects had
2-h daily training sessions with no cocaine delivery (saline
was substituted for cocaine) or presentation of the condition-
ing stimulus. Once they reached the extinction criteria (10
extinction days with the last 3 days in which active lever
responses were below 10% of the level observed during the
maintenance period), on the 10th day of extinction, the ani-
mals were sacrificed immediately following the last (2-h) ex-
perimental session (group 2; N = 7).
Yoked Self-Administration Procedure
The rats were tested simultaneously in groups of three, with
two rats serving as Byoked^ controls that received an injec-
tion of saline (N = 6–7) or cocaine (N = 6–7) which was not
contingent on their response and occurred each time a
response-contingent injection of 0.5 mg/kg of cocaine was
self-administered by the paired rat. For yoked saline and
yoked cocaine controls, the 5-s presentation of a stimulus
complex (see above) was present during the infusion
followed by the 20-s time-out period. Unlike self-
administering rats, lever pressing by the yoked rats was
recorded but had no programmed consequences
(Frankowska et al. 2008).
Immunohistochemistry Procedures
Immediately after the experimental sessions, the rats were
injected with pentobarbital and perfused intracardially with a
solution of 4% paraformaldehyde in 100 mM phosphate-
buffered saline (PBS), pH = 7.4. The brains were excised
and postfixed in the same fixative for 12 h. The tissue was
permeated with 10% w/v sucrose for 7 days and then removed
to a 30%w/v sucrose solution in PBS at 4–8 °C for a minimum
of 48 h. The brains were fully frozen on dry ice, cut into
12-μm coronal sections on a cryostat (Leica Microsystems,
Nussloch, Germany), and kept at − 20 °C until they were
processed for immunohistochemical analysis. Later, the rat
brain sections were rinsed in 100 mM PBS (pH = 7.4) and in
PBS containing 0.1% Triton X-100 for 30 min at room tem-
perature (RT). They were then rinsed with Odyssey Blocked
Buffer (OBB) for 1 h at room temperature. The tissue sections
were incubated overnight at 4 °C with the following purified
primary antibodies in OBB containing 0.1% Tween 20: rabbit
anti-CB1 (1:200 dilution, Abcam, ab23703) and goat anti-
CB2 (1:200 dilution, Santa-Cruz, sc10076). Following four
5-min washes with PBS containing 0.1% Tween 20, the tissue
sections were incubated for 1 h at room temperature with goat
anti-rabbit (IRDye® 680CW) and donkey anti-goat (IRDye®
800CW) secondary antibodies (Li-COR Biosciences,
Cambridge, UK) at a dilution of 1:2000. Fluorescence was
detected using the Odyssey® Infrared Imaging System
(21-μm resolution, 1-mm offset at the highest resolution).
The integrated intensities were determined with the associated
Odyssey software. Each section was prescanned at different
intensity settings on the Odyssey Classic Infrared Imaging
System. Channel sensitivity was optimized for each set of
stained sections, and channel intensity varied from 3 to 5.
The latter allows detection of nonspecific background signals
from the sample and permits gross localization of the cerebral
tissue. The relative location of the slices and the identification
of brain regions were determined via comparisons to the im-
ages in The Rat Brain Atlas (1998). Schematic illustrations of
rat brain structures are shown in Fig. 1, and representative
coronal sections of rat brains immunostained for the CB1
and CB2 receptors after 14 days of passive saline administra-
tion are shown in Fig. 2.
Data Analysis
Animals that did not meet the training criteria for performing
cocaine self-administration (N = 2) and extinction (N = 1) or
those showing incorrect perfusion (N = 3) were excluded from
the data analysis. All data are expressed as the means (±
SEM). Behavioral data were analyzed using a two-way
ANOVA for repeated measures followed by post hoc
Newman-Keuls tests. Immunohistochemical data were ana-
lyzed using a one-way ANOVA, and appropriate post hoc
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comparisons were performed using Newman-Keuls tests. The
results with a p value < 0.05 were considered statistically
significant.
Results
Behavioral Studies
After the self-administration sessions, animals in the two ex-
perimental groups showed stable lever-pressing rates during
the last three self-administration days, with less than a 10%
difference in their daily intake of cocaine (Fig. 2). The mean
number of cocaine infusions per day during the last three self-
administration days varied from 26 to 29. During 14 experi-
mental sessions, the animals received from 158.0 to 176.4 mg/
kg of cocaine each. Rats trained to self-administer cocaine
(group 1) pressed on the active lever significantly more fre-
quently than they pressed on the inactive lever from the 4th to
the 14th experimental session, as assessed by the lever × day
session interaction (F(13,130) = 4.65, p < 0.001).
Following 14 days of cocaine self-administration, the ex-
tinction training started for a separate group of animals. In this
phase, neither drug nor drug-paired stimuli were given in re-
sponse to lever pressing, which resulted in a gradual decrease
in active lever presses. In the group of rats decapitated on the
10th day of extinction training, the animals pressed on the
active lever more frequently than they pressed on the inactive
lever from the 2nd cocaine self-administration session until
the 1st day of extinction training (F(23,276) = 11.52, p < 0.001).
In the yoked saline and cocaine groups, the animals re-
ceived saline or the same amount of cocaine at the same time
as the animals that learned to self-inject cocaine, respectively.
In the yoked cocaine groups, the total number of active lever
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Fig. 2 The number of Bactive^ and Binactive^ lever presses in rats underwent cocaine (0.5 mg/kg/infusion) self-administration (left panels; group 1) or 10-daily
cocaine abstinence with extinction training (right panels, group 2). Data are presented as the mean ± SEM. ***p< 0.0001 versus Binactive^ lever
Fig. 1 Representative coronal sections of rat brain immunostaining for
CB1 and CB2 receptors after 14 days of passive saline administration
(control group). The panels are gray scale images of individual
antibodies. BLA basolateral and basomedial amygdala, DST dorsal
striatum, HIP hippocampus, LSN lateral septal nucleus, MGP medial
globus pallidus, NAc core nucleus accumbens core, NAc shell nucleus
accumbens shell, PFC prefrontal cortex, SN substantia nigra, VTAventral
tegmental area
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presses did not differ from the inactive lever as shown by a
two-way ANOVA for repeated measures (14 days with yoked
cocaine delivery (F(13,130) = 1.02); 14 days with yoked co-
caine delivery and 10 days of cocaine abstinence (F(23,276) =
0.98)); however, some increases in the active lever presses
were seen during the initial three to four experimental sessions
due to associate learning that was occurring in the yoked con-
trol groups. In the yoked saline groups (14 days with yoked
saline delivery as well as 24 days with yoked saline delivery),
the difference in pressing the active versus the inactive lever
failed to reach significance (F(13,130) = 0.37 and F(23,276) =
0.29, respectively).
Expression of the CB1 and CB2 Receptor Protein
As shown in Figs. 3a and 5, cocaine self-administration in rats
resulted in a decrease in the expression CB1 receptor proteins
in the prefrontal cortex (F(2,15) = 9.239; p < 0.01), basolateral
and basomedial amygdala (F(2,15) = 22.906; p < 0.001) and
dorsal striatum (F(2,15) = 5.497; p < 0.05), whereas in the nu-
cleus accumbens shell of the yoked cocaine controls, there
was a significant increase in CB1 receptor expression
(F(2,15) = 4.344; p < 0.05). In both cocaine groups, we found
enhanced (> 50%) tegmental CB1 receptor protein expression
(F(2,15) = 6.668; p < 0.01). There were no changes in CB1 re-
ceptor protein expression in the lateral septal nuclei (F(2,15) =
0.413), nucleus accumbens core (F(2,15) = 1.673), medial
globus pallidus (F(2,15) = 0.756), hippocampus (F(2,15) =
2.074), and substantia nigra (F(2,15) = 0.574), as revealed by
a one-way ANOVA (for all, p > 0.05).
The 10-daily cocaine abstinence period with extinction
training sessions in rats self-administered cocaine evoked the
statistically significant reduction in CB1 receptor expression
in the medial globus pallidus (F(2,18) = 4.097; p < 0.05) (Figs.
3b and 5). However, there was a significant increase in CB1
receptor expression in the substantia nigra (F(2,18) = 17.026; p
< 0.001) in both cocaine groups and in the basolateral and
basomedial amygdala (F(2,18) = 8.927; p < 0.01) in the
cocaine-yoked controls. Cocaine abstinence did not change
CB1 receptor expression in the prefrontal cortex (F(2,18) =
1.279), hippocampus (F(2,18) = 1.489), nucleus accumbens
shell (F(2,18) = 1.428), nucleus accumbens core (F(2,18) =
0.397), lateral septal nuclei (F(2,18) = 3.231), dorsal striatum
(F(2,18) = 0.845), and ventral tegmental area (F(2,18) = 0.900;
p > 0.05), as assessed by a one-way ANOVA (p > 0.05).
Cocaine self-administration produced a statistically signif-
icant decrease in CB2 receptor protein expression in the
basolateral and basomedial amygdala (F(2,15) = 5.489; p <
0.05). As demonstrated for the nucleus accumbens shell,
yoked cocaine administration increased the expression of
CB2 proteins (F(2,15) = 8.778; p < 0.01). There were no chang-
es in either cocaine group in CB2 receptor expression (p >
0.05) in the prefrontal cortex (F(2,15) = 0.816), hippocampus
(F(2,15) = 1.374), nucleus accumbens core (F(2,15) = 1.022), lat-
eral septal nuclei (F(2,15) = 0.932), dorsal striatum (F(2,15) =
1.701), medial globus pallidus (F(2,15) = 0.542), substantia
nigra (F(2,15) = 0.429), and VTA (F(2,15) = 2.601) (Figs. 4a
and 5), as shown by a one-way ANOVA.
Cocaine abstinence in both cocaine groups altered CB2
receptor protein expression, with significant (> 40%) de-
creases observed in the prefrontal cortex (F(2,18) = 7.305; p <
0.01), nucleus accumbens core (F(2,18) = 7.638; p < 0.01), and
medial globus pallidus (F(2,18) = 6.051; p < 0.01). There were
no changes (p > 0.05; one-way ANOVA) in CB2 receptor
protein expression in the hippocampus (F(2,18) = 0.809),
basolateral and basomedial amygdala (F(2,18) = 4.206), nucle-
us accumbens shell (F(2,18) = 0.087), lateral septal nuclei
(F(2,18) = 1.014), dorsal striatum (F(2,18) = 0.647), substantia
nigra (F(2,18) = 1.989), and ventral tegmental area (F(2,18) =
0.282) (Figs. 4b and 5).
Discussion
Agrowing number of behavioral studies support the important
role of eCB signaling in substance use disorder, including
cocaine addiction (Mereu et al. 2015; Onaivi 2008; Serrano
and Parsons 2011; Adamczyk et al. 2012b; Fattore et al. 1999;
Filip et al. 2006). The present results extend our previous
neurochemical observations (Adamczyk et al. 2012a;
Bystrowska et al. 2014) and behavioral (Adamczyk et al.
2012b) observations as well as further outline the significance
of the eCB system and its receptors in the reinforcing and
motivational effects of cocaine.
We report here that cocaine self-administration for 14 days
in 2-h daily sessions in rats causes a significant reduction in
CB1 receptor expression in the prefrontal cortex, basolateral
and basomedial amygdala, and dorsal striatum. These changes
did not appear (except in the amygdala) after repeated passive
iv cocaine exposure, indicating that these effects may be
linked to the motivational, associate learning and/or locomo-
tor aspects of cocaine intake. Immunohistochemical staining
also revealed a large increase (> 60%) in CB1 receptor expres-
sion in the ventral tegmental area as a result of the pharmaco-
logical aspects of cocaine use, as revealed after both voluntary
or passive psychostimulant intake, and/or the Pavlovian asso-
ciations between drug delivery and the conditioned stimulus
(the tone+light associated with cocaine infusions).
Furthermore, the above changes in CB1 receptor expres-
sion disappeared after extinction training, when a 50% reduc-
tion in CB1 receptor expression in rats with a history of co-
caine self-administration and a > 100% increase in receptor
protein expression after previous active or passive cocaine
injections were noted. Interestingly, it was only in the
cocaine-yoked controls that cocaine abstinence evoked a
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significant increase in CB1 receptor expression in the rat
amygdala.
The present data extend our previous observations on brain
tissue eCB levels using the same behavioral protocol in rats
(Bystrowska et al. 2014). Moreover, our neurochemical ex
vivo results support previously obtained direct in vivo evi-
dence of cocaine-induced alterations in the nucleus accum-
bens of mice as well as behavioral data on cocaine self-
administration following intra-accumbal injections of a CB1
receptor antagonist (Caillé et al. 2007). However, other phar-
macological and genetic approaches have not supported the
idea that cocaine-induced reward behavior is sensitive to this
type of CB1 receptor manipulation (Chaperon et al. 1998;
Martin et al. 2000; Tanda et al. 2000; Adamczyk et al.
2012a; Fattore et al. 1999; Filip et al. 2006). Although it is
difficult to explain the above differences, a recent paper by
Martín-García et al. (2016) shows that CB1 receptors—local-
ized mainly to glutamatergic and GABAergic neuronal
systems in the brain—are involved in different aspects of co-
caine addiction (Martín-García et al. 2016). Using mutant
mice with CB1 receptors deleted from their cortical gluta-
matergic neurons (i.e., in the cortex, hippocampus, and corti-
cal portions of the amygdala) and from the GABAergic neu-
rons in their forebrain (i.e., in the whole striatum, thalamus,
and hypothalamus), these authors found that CB1 receptors in
cortical glutamatergic neurons control associative learning
processes, whereas CB1 receptors in GABAergic neurons in
the forebrain control the sensitivity to cocaine. Based on these
observations, the reductions in CB1 receptor expression in
cortical and amygdaloidal structures presented in this paper
may reflect the cocaine-induced facilitation of associative
learning, which is a key process controlling cocaine use
(Hogarth et al. 2013; Voon et al. 2014), and the perception
of the drug’s importance, respectively. Regarding the striatum,
it plays a role in skill learning, instrumental conditioning,
habit formation, and the transition from voluntary to habitual
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Fig. 3 Immunohistochemical analyses for the CB1 receptor expression in
the rat brain structures following cocaine (0.5 mg/kg/infusion) self-
administration (a) and 10-daily cocaine abstinence with extinction train-
ing (b). Active cocaine—rats self-administering cocaine; Yoked co-
caine—rats received passively cocaine; Yoked saline—rats received
passively saline. For more explanation see Fig. 1. N = 6 rats/group for
cocaine self-administration;N = 7 rats/group for cocaine abstinence. *p <
0.05, **p < 0.01, ***p < 0.001 vs Yoked saline; ^p < 0.05, ^^p < 0.01,
^^^p < 0.001 vs Active cocaine (Newman-Keuls test)
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drug seeking (Everitt and Robbins 2013) and CB1 receptor
deletion from olfactory-dorsal striatal neurons prevents the
shift from goal-directed to habitual action control (Gremel et
al. 2016). It should also be added that between the basolateral
amygdala (i.e., a primary locus in mediating the associations
between the input of a drug stimulus and the subsequent drug-
seeking behavior) and the nucleus accumbens core/dorsal stri-
atum, there are direct glutamatergic interactions that control
cocaine-seeking behavior in rats (Di Ciano and Everitt 2004).
Our data suggest that drugs modulating eCB transmission at
CB1 receptors may be useful in future treatments to reduce the
incentive value of the cocaine-associated reward or to prevent
cocaine addiction through the blockade of memory
reconsolidation.
In contrast to the above noted decreases in expression
linked (mainly) to voluntary cocaine intake, the increases ob-
served in tegmental CB1 receptor expression seem to be a
pharmacological effect of cocaine delivery. It should also be
noted that cocaine delivery in self-administering rats and
yoked drug controls are linked with a conditioned stimulus,
and the ventral tegmental area plays a significant role in learn-
ing and habit formation (Barker and Rebec 2016). In fact,
Wang et al. (2015) recently demonstrated the control of teg-
mental CB1 receptors over cocaine-induced synaptic plastici-
ty and associative learning (Wang et al. 2015). The latter pro-
cess has also been found to occur in rats given a passive drug
injection in conditioned place preference trials and were found
to be linked with the cocaine-induced enhancement of
extrasynaptic 2-AG that acts via presynaptic CB1 receptor
activation to inhibit GABAergic inputs to GABAB receptors
localized at the dopamine neurons. Further in vivo studies are
required to determine if tegmental CB1 receptors are a critical
biomarker involved in both acquiring and retrieving cocaine-
associated memories.
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0.05, **p < 0.01, ***p < 0.001 vs Yoked saline; ^^p < 0.01 vs Active
cocaine (Newman-Keuls test)
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The nucleus accumbens is a gateway for emotional, moti-
vational, or locomotor responses. Although the level of ex-
pression of CB1 receptors in this brain structure is low, they
are localized to afferents to the nucleus accumbens and to
accumbal fast-spiking interneurons (Winters et al. 2012).
Furthermore, CB1 receptor-expressing fast-spiking interneu-
rons form GABAergic synapses with adjacent medium spiny
neurons, which generate a feed-forward inhibition of
accumbal output. As shown previously, cocaine self-
administration and noncontingent exposure to cocaine reduce
the membrane excitability of medium spiny neurons
(Ishikawa et al. 2009; Mu et al. 2010), and cocaine acts on
CB1 receptors localized to fast-spiking interneurons to further
increase their inhibitory influence over medium spiny neurons
(Winters et al. 2012). As ventral striatopallidal GABA neu-
rons (Trifilieff et al. 2011) represent an antireward system
modulating the glutamate drive to the prefrontal cortex over
the ventral pallidum and the dorsomedial thalamic nucleus
(Fuxe et al. 2008), CB1 receptors in the nucleus accumbens
may be neu r ona l t a rg e t s f o r co ca i n e - i nduced
neuroadaptations.
As mentioned above, the pattern of CB1 receptor expres-
sion was different during the cocaine-free period. Thus,
10 days of cocaine abstinence that included extinction training
caused bi-phasic changes in the pattern of CB1 receptor ex-
pression, with a significant decrease in expression in the me-
dial globus pallidus and a potent increase in expression in the
substantia nigra. The globus pallidus is responsible, in addi-
tion to its other roles, for controlling cocaine-seeking behav-
iors, and the reduction in the expression of CB1 receptors on
striatopallidal axons in the globus pallidus may disturb the
presynaptic inhibition of GABA neurotransmission and
Fig. 5 Representative coronal
sections of rat brain
immunostaining for CB1 and
CB2 receptors after cocaine self-
administration and 10-daily co-
caine abstinence with extinction
training. The panels are gray scale
images of individual antibodies.
Active cocaine (AC)—rats self-
administering cocaine; Yoked co-
caine (YC)—rats received pas-
sively cocaine; Yoked saline
(YS)—rats received passively
saline
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globus pallidus neurons, which in turn could allow for multi-
phasic motor effects such as cocaine seeking (Engler 2005;
Gonzalez et al. 2009). This hypothesis needs to be confirmed
using functional assays. On the other hand, we demonstrate
that cocaine abstinence in yoked cocaine controls resulted in a
significant enhancement of CB1 receptor expression in the
basolateral amygdala. There are literature data showing that
basolateral amygdala integrates and processes emotions such
as fear and anxiety that promote survival by warning of po-
tential danger (Sharp 2017) and that basolateral eCB system
may be involved in regulating the stress responses, fear, and
anxiety (Gorzalka et al. 2008; Hill and Gorzalka 2004; Hill et
al. 2008; Nasehi et al. 2018). As yoked cocaine can evoke a
stress response in rats, a rise in CB1 receptor expression in this
region might reflect disrupted EC signaling with an inability
to adapt to stress.
This study also suggests that the CB1-receptor-mediated
plasticity of dopamine neurons in the substantia nigra can
contribute to cocaine-induced modulation at a cellular lev-
el. Supporting this idea, previous research shows that the
substantia nigra and its dopamine neurons are engaged in
the rewarding aspects of cocaine use (Ilango et al. 2014;
Ramayya et al. 2014; Rossi et al. 2013; Wise 2009). On
the other hand, a rise in CB1 protein expression in the
substantia nigra of yoked cocaine animals which were ex-
posed to cues, and—despite the possibility to associate the
drug cue to the operant response—they formed a Pavlovian
association between the cue presentation and cocaine ef-
fects which were messed during animals’ exposure to ex-
perimental chambers in the absence of cocaine and its cue.
Since the findings also demonstrate a critical function of the
nigrostriatal dopamine system in controlling actions as the
dopamine neurons in the substantia nigra were excited dur-
ing a Pavlovian procedure with appetitive and aversive out-
comes (Matsumoto and Hikosaka 2009), it may be consid-
ered here that the nigral CB1 receptor may signal—through
the midbrain dopaminergic neurons—the occurrence of
unpredicted reward, which is used in appetitive learning
to reinforce existing actions (Redgrave and Gurney 2006;
Schultz 2007).
In the next set of experiments, we showed the signifi-
cance of CB2 receptors in cocaine-induced behaviors.
Compared to the levels in peripheral organs (e.g., the
spleen), the brain CB2 mRNA and protein levels are very
low, and the molecules are localized mainly at astrocytes
(Aracil-Fernández et al. 2012; Baek et al. 2013; Ashton et
al. 2006; Zhang et al. 2014). Recent findings have demon-
strated the wide distribution of CB2 receptors in rodent
brains in tegmental dopaminergic and nondopaminergic
neurons (Zhang et al. 2015; Aracil-Fernández et al. 2012;
Zhang et al. 2014; Zhang et al. 2016) and in hippocampal
pyramidal neurons (Kim and Li 2015; Li and Kim 2015)
and have shown the presence of striatal GABAergic
neurons in nonhuman primates (Lanciego et al. 2011;
Sierra et al. 2015).
In the present paper, we detected a significant reduction
of CB2 receptor expression in the basolateral and
basomedial amygdala which may be linked to the motiva-
tional aspects of cocaine intake. There was a potent increase
in the expression of this receptor protein in the accumbal
shell in the yoked cocaine controls and a nonsignificant
increase in CB2 receptor expression in the ventral tegmen-
tal area in both cocaine groups. Until now, a single report
indicated that cocaine self-administration upregulates CB2
mRNA expression in the prefrontal cortex and striatum and
in tegmental dopaminergic neurons (Zhang et al. 2016).
Whether our and the later authors’ findings speak for the
engagement of brain CB2 receptors in cocaine reward or
locomotor actions, further functional studies are required.
So far, the enhancement of CB2 receptor function via phar-
macological or genetic (Ignatowska-Jankowska et al. 2013;
Xi et al. 2011; Zhang et al. 2014; Zhang et al. 2015) manip-
ulations inhibits cocaine-associated locomotion, self-ad-
ministration, and conditioned place preference in rodents
(Aracil-Fernández et al. 2012).
This is also the first report showing a cocaine-induced
change in CB2 receptor expression in the drug-free peri-
od. In fact, there was significant reduction in CB2 recep-
tor expression in prefrontal cortex, nucleus accumbens
core, and globus pallidus in both cocaine-experienced
groups of animals. First, we postulated that the observed
molecular processes of the eCB signaling at CB2 cannot
be linked directly to messed contextual encoding of ex-
tinction or enhanced extinction consolidation, as such ef-
fects should be observed only in animals with a history of
cocaine self-administration. On the other hand, the reduc-
tion in CB2 receptor signaling in the prefrontal cortex
may reflect diminished emotional recognition that oc-
curred in cocaine abstinent rats. In fact, the overexpres-
sion of CB2 receptors reduces anxiogenic behaviors and
modifies the stress response (Ignatowska-Jankowska et al.
2013; Xi et al. 2011; Zhang et al. 2014, Zhang et al.
2015), and brain CB2 receptors are also functionally in-
volved in depressive behaviors (García-Gutiérrez et al.
2010; García-Gutiérrez and Manzanares 2011). Changes
in CB2 receptor expression in the amygdala—a brain
structure responsible for detecting fear and preparing for
emergency events—may also be a marker of mood distur-
bances that occurred in yoked cocaine control rats. In fact,
stress is an inherent complication for yoked animals, and
the aversive procedure can reduce the motivational aspect
of cocaine (Twining et al. 2009) and enhances the stress
hormone (corticosterone) levels. However, the signifi-
cance of CB2 receptor alterations in cocaine abstinence
needs to be determined in functional studies with using
pharmacological tools.
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Conclusion
As shown in this study, alterations in the expression of CB1
and CB2 proteins in rat brain structures indicate their impor-
tance to cocaine-induced reward and drug-seeking behaviors.
Defining the functional role of a particular cannabinoid recep-
tor in cocaine use disorder and determining whether the phar-
macological modulation of this system may be an effective
therapy for drug addiction requires further investigations.
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